Our two T-ALL cases were also characterized by aberrant expression of TLX3. T-ALL patients co-expressing TLX3 and NUP214::ABL1 fusion transcript may belong to a subgroup of poor survival (39). This evidence concerns the gene NUP214 and acute lymphoblastic leukemia.